Alamar Biosciences, Inc. (California) (ALMR)
34.36
+1.90
(+5.85%)
USD |
NASDAQ |
Oct 02, 16:00
34.62
+0.26
(+0.76%)
Pre-Market: 20:00
Alamar Biosciences EPS Diluted (Quarterly) : -0.1902 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1902 |
| March 31, 2026 | -0.3077 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.1013 |
| March 31, 2025 | -0.1105 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| 10X Genomics, Inc. | -0.138 |
| Personalis, Inc. | -0.3005 |
| Adaptive Biotechnologies Corp. | -0.2489 |
| Champions Oncology, Inc. | -0.0306 |
| Medpace Holdings, Inc. | 4.250 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.20M |
| Revenue (Quarterly) | 29.43M |
| Total Expenses (Quarterly) | 42.63M |
| Enterprise Value | 2.186B |
| Gross Profit Margin (Quarterly) | 60.21% |
| Profit Margin (Quarterly) | -44.85% |
| Earnings Yield | -2.07% |
| Normalized Earnings Yield | -1.772 |